Cargando…
CRISPR-Cas System: The Current and Emerging Translational Landscape
CRISPR-Cas technology has rapidly changed life science research and human medicine. The ability to add, remove, or edit human DNA sequences has transformative potential for treating congenital and acquired human diseases. The timely maturation of the cell and gene therapy ecosystem and its seamless...
Autores principales: | Bhokisham, Narendranath, Laudermilch, Ethan, Traeger, Lindsay L., Bonilla, Tonya D., Ruiz-Estevez, Mercedes, Becker, Jordan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136740/ https://www.ncbi.nlm.nih.gov/pubmed/37190012 http://dx.doi.org/10.3390/cells12081103 |
Ejemplares similares
-
A redox-based electrogenetic CRISPR system to connect with and control biological information networks
por: Bhokisham, Narendranath, et al.
Publicado: (2020) -
CRISPR/Cas9 Landscape: Current State and Future Perspectives
por: Tyumentseva, Marina, et al.
Publicado: (2023) -
CRISPR-Cas, Argonaute proteins and the emerging landscape of amplification-free diagnostics
por: Santiago-Frangos, Andrew, et al.
Publicado: (2022) -
A Landscape of CRISPR/Cas Technique for Emerging Viral Disease Diagnostics and Therapeutics: Progress and Prospects
por: Tripathi, Shyam, et al.
Publicado: (2022) -
Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies
por: Hanel, Walter, et al.
Publicado: (2021)